A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

NCT ID: NCT06877884

Last Updated: 2025-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

20000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-01

Study Completion Date

2099-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent

Exclusion Criteria

Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative
Minimum Eligible Age

18 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

N-Power Medicine

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pacific Cancer Care

Monterey, California, United States

Site Status RECRUITING

Bayhealth Cancer Center-Kent

Dover, Delaware, United States

Site Status RECRUITING

Bayhealth Cancer Center- Sussex

Milford, Delaware, United States

Site Status RECRUITING

Northwest Oncology & Hematology

Elk Grove Village, Illinois, United States

Site Status RECRUITING

New Mexico Oncology Hematology Consultants

Albuquerque, New Mexico, United States

Site Status RECRUITING

Lankenau Medical Center

Paoli, Pennsylvania, United States

Site Status RECRUITING

Oncology Consultants, P.A.

Houston, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christer Svedman, MD

Role: CONTACT

833-467-6734

Louise Polychronopoulos, PhD

Role: CONTACT

833-467-6734

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

NPM Study Coordinator

Role: primary

831-375-4105

Registry Help Line

Role: backup

833-4NPM-REG

Stephanie McClellan

Role: primary

814-744-7995

Stephanie McClellan

Role: primary

302-744-7995

Nowsheen Azeemuddin

Role: primary

847-437-3312

Registry Help Line, 833-4NPM-REG

Role: backup

Role: primary

Registry Help Line

Role: backup

833-4NPM-REG

Jessica Burrell

Role: primary

484-476-2649

Research Lead

Role: primary

713-600-0913

Role: backup

1-833-4NPM-REG

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NPM-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Norris ORIEN Total Cancer Care
NCT02970045 RECRUITING